Asset Dedication LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $277K | Buy |
4,807
+452
| +10% | +$26K | 0.02% | 293 |
|
|
2026
Q1 | $264K | Buy |
4,355
+19
| +0.4% | +$1.11K | 0.02% | 284 |
|
|
2025
Q4 | $234K | Sell |
4,336
-2,397
| -36% | -$115K | 0.02% | 295 |
|
|
2025
Q3 | $304K | Sell |
6,733
-320
| -5% | -$14.9K | 0.02% | 271 |
|
|
2025
Q2 | $326K | Buy |
7,053
+441
| +7% | +$21.6K | 0.02% | 257 |
|
|
2025
Q1 | $403K | Sell |
6,612
-7,875
| -54% | -$459K | 0.03% | 224 |
|
|
2024
Q4 | $819K | Buy |
14,487
+8,041
| +125% | +$449K | 0.06% | 168 |
|
|
2024
Q3 | $334K | Sell |
6,446
-1,241
| -16% | -$58.2K | 0.02% | 271 |
|
|
2024
Q2 | $319K | Sell |
7,687
-2,936
| -28% | -$131K | 0.02% | 272 |
|
|
2024
Q1 | $571K | Sell |
10,623
-413
| -4% | -$21K | 0.04% | 216 |
|
|
2023
Q4 | $563K | Sell |
11,036
-7,036
| -39% | -$369K | 0.05% | 221 |
|
|
2023
Q3 | $1.05M | Sell |
18,072
-163
| -0.9% | -$9.99K | 0.09% | 168 |
|
|
2023
Q2 | $1.16M | Sell |
18,235
-3,075
| -14% | -$206K | 0.1% | 163 |
|
|
2023
Q1 | $1.48M | Buy |
21,310
+1,469
| +7% | +$104K | 0.14% | 128 |
|
|
2022
Q4 | $1.43M | Sell |
19,841
-578
| -3% | -$43.6K | 0.15% | 126 |
|
|
2022
Q3 | $1.46M | Buy |
+20,419
| New | +$1.48M | 0.16% | 115 |
|
|
2022
Q2 | – | Sell |
-19,668
| Closed | -$1.44M | – | 545 |
|
|
2022
Q1 | $1.44M | Buy |
19,668
+3,561
| +22% | +$239K | 0.16% | 119 |
|
|
2021
Q4 | $1M | Sell |
16,107
-4,554
| -22% | -$267K | 0.12% | 136 |
|
|
2021
Q3 | $1.22M | Buy |
20,661
+359
| +2% | +$23.6K | 0.16% | 113 |
|
|
2021
Q2 | $1.36M | Buy |
20,302
+4,738
| +30% | +$309K | 0.2% | 105 |
|
|
2021
Q1 | $976K | Sell |
15,564
-4,145
| -21% | -$258K | 0.22% | 106 |
|
|
2020
Q4 | $1.22M | Buy |
19,709
+2,369
| +14% | +$146K | 0.24% | 99 |
|
|
2020
Q3 | $1.04M | Buy |
17,340
+1,757
| +11% | +$106K | 0.23% | 105 |
|
|
2020
Q2 | $911K | Buy |
15,583
+976
| +7% | +$58.4K | 0.25% | 99 |
|
|
2020
Q1 | $816K | Buy |
14,607
+3,512
| +32% | +$215K | 0.24% | 103 |
|
|
2019
Q4 | $709K | Buy |
11,095
+1,759
| +19% | +$101K | 0.2% | 112 |
|
|
2019
Q3 | $472K | Buy |
9,336
+5,058
| +118% | +$238K | 0.16% | 119 |
|
|
2019
Q2 | $194K | Sell |
4,278
-918
| -18% | -$42.8K | 0.06% | 163 |
|
|
2019
Q1 | $247K | Buy |
5,196
+551
| +12% | +$27.4K | 0.09% | 142 |
|
|
2018
Q4 | $243K | Sell |
4,645
-499
| -10% | -$26.8K | 0.1% | 136 |
|
|
2018
Q3 | $318K | Sell |
5,144
-241
| -4% | -$14.3K | 0.12% | 131 |
|
|
2018
Q2 | $297K | Buy |
5,385
+1,089
| +25% | +$58.8K | 0.1% | 134 |
|
|
2018
Q1 | $271K | Buy |
4,296
+576
| +15% | +$37.1K | 0.13% | 120 |
|
|
2017
Q4 | $229K | Buy |
3,720
+732
| +24% | +$45.8K | 0.09% | 140 |
|
|
2017
Q3 | $189K | Buy |
2,988
+446
| +18% | +$26K | 0.09% | 131 |
|
|
2017
Q2 | $141K | Hold |
2,542
| – | – | 0.07% | 148 |
|
|
2017
Q1 | $139K | Buy |
2,542
+351
| +16% | +$19.3K | 0.08% | 144 |
|
|
2016
Q4 | $129K | Sell |
2,191
-148
| -6% | -$8.09K | 0.07% | 152 |
|
|
2016
Q3 | $128K | Buy |
2,339
+1,850
| +378% | +$119K | 0.08% | 141 |
|
|
2016
Q2 | $36K | Buy |
489
+49
| +11% | +$3.46K | 0.03% | 204 |
|
|
2016
Q1 | $28K | Sell |
440
-563
| -56% | -$35.5K | 0.02% | 219 |
|
|
2015
Q4 | $69K | Buy |
+1,003
| New | +$66.3K | 0.05% | 207 |
|
Other funds holding BMY
Asset Dedication LLC's BMY Position: Q2 2026 in Review
Asset Dedication LLC increased its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, buying an estimated $26K and bringing the position to 4,807 shares worth $277K. The position accounts for 0.02% of the portfolio, ranked #293.
Asset Dedication LLC first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.48M in Q1 2023. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Asset Dedication LLC held 4,807 shares of Bristol-Myers Squibb worth $277K as of Q2 2026.
- Asset Dedication LLC bought 452 Bristol-Myers Squibb shares in Q2 2026, an estimated $26K.
- Bristol-Myers Squibb made up 0.02% of Asset Dedication LLC's portfolio in Q2 2026, its #293 holding.
- Asset Dedication LLC first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
- Asset Dedication LLC's Bristol-Myers Squibb position peaked at $1.48M in Q1 2023.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.